Medicure (MCUJF) Non-Current Deferred Tax Liability (2016 - 2017)
Medicure's (MCUJF) quarterly Non-Current Deferred Tax Liability came in at $478968.2 in Q4 2017, down 98.33% year-on-year from $28.6 million in Q4 2016, and down 98.14% quarter-over-quarter from $25.8 million in Q3 2017.
Medicure (MCUJF) Non-Current Deferred Tax Liability (2016 - 2017) Analysis & Trends
Medicure's Non-Current Deferred Tax Liability history runs 2 years deep, the most recent figure standing at $478968.2 for Q4 2017.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 98.33% year-over-year to $478968.2 in Q4 2017; TTM through Dec 2017 was $478968.2, a 98.33% decrease from a year earlier, with the FY2017 full-year figure at $469025.3, down 98.36% from the prior year.
- Non-Current Deferred Tax Liability retreated to $478968.2 in Q4 2017 per MCUJF's latest filing, from $25.8 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $28.6 million in Q4 2016 and bottomed at $478968.2 in Q4 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 478,968.19 |
| Dec 31, 2017 | 478,968.19 |
| Sep 30, 2017 | 25.78 Mn |
| Sep 30, 2017 | 25.78 Mn |
| Jun 30, 2017 | 26.45 Mn |
| Jun 30, 2017 | 26.45 Mn |
| Mar 31, 2017 | 27.06 Mn |
| Mar 31, 2017 | 27.06 Mn |
| Dec 31, 2016 | 28.60 Mn |
| Dec 31, 2016 | 28.60 Mn |